Cargando…

Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells

Epstein-Barr virus (EBV) is a human herpesvirus associated with B-cell and epithelial cell malignancies. EBV lytically infects normal differentiated oral epithelial cells, where it causes a tongue lesion known as oral hairy leukoplakia (OHL) in immunosuppressed patients. However, the cellular mechan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nawandar, Dhananjay M., Wang, Anqi, Makielski, Kathleen, Lee, Denis, Ma, Shidong, Barlow, Elizabeth, Reusch, Jessica, Jiang, Ru, Wille, Coral K., Greenspan, Deborah, Greenspan, John S., Mertz, Janet E., Hutt-Fletcher, Lindsey, Johannsen, Eric C., Lambert, Paul F., Kenney, Shannon C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592227/ https://www.ncbi.nlm.nih.gov/pubmed/26431332 http://dx.doi.org/10.1371/journal.ppat.1005195

Ejemplares similares

Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus’s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter
por: Kraus, Richard J., et al.
Publicado: (2017)

ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells
por: Van Sciver, Nicholas, et al.
Publicado: (2021)

Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription
por: Ali, Ahmed, et al.
Publicado: (2022)

Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
por: Bilger, Andrea, et al.
Publicado: (2017)

Epstein-Barr virus infection mechanisms
por: Chesnokova, Liudmila S., et al.
Publicado: (2014)

ZEB1 Regulates the Latent-Lytic Switch in Infection by Epstein-Barr Virus
por: Yu, Xianming, et al.
Publicado: (2007)

A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection
por: Bristol, Jillian A., et al.
Publicado: (2018)

Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells
por: Van Sciver, Nicholas, et al.
Publicado: (2021)

CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms
por: Djavadian, Reza, et al.
Publicado: (2018)

An Epstein-Barr Virus-Encoded Protein Complex Requires an Origin of Lytic Replication In Cis to Mediate Late Gene Transcription
por: Djavadian, Reza, et al.
Publicado: (2016)

Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell Cycle
por: Eichelberg, Mark R., et al.
Publicado: (2019)

Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
por: Gorres, Kelly L., et al.
Publicado: (2016)

Inhibitory Effects of Resveratrol on the Epstein-Barr Virus Lytic Cycle
por: Yiu, Ching-Yi, et al.
Publicado: (2010)

Functional Implications of Epstein-Barr Virus Lytic Genes in Carcinogenesis
por: Yap, Lee Fah, et al.
Publicado: (2022)

Epstein–Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma
por: Hoebe, Eveline, et al.
Publicado: (2018)

Epstein–Barr Virus: How Its Lytic Phase Contributes to Oncogenesis
por: Rosemarie, Quincy, et al.
Publicado: (2020)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

Activation of the Epstein–Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli
por: MacNeil, A, et al.
Publicado: (2003)

Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis
por: Li, Hongde, et al.
Publicado: (2016)

Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
por: Anderson, Abbie G., et al.
Publicado: (2019)

Arsenicals, the Integrated Stress Response, and Epstein–Barr Virus Lytic Gene Expression
por: Lee, Jaeyeun, et al.
Publicado: (2021)

Replication Compartments—The Great Survival Strategy for Epstein–Barr Virus Lytic Replication
por: Sugimoto, Atsuko
Publicado: (2022)

Complexities associated with expression of Epstein–Barr virus (EBV) lytic origins of DNA replication
por: Xue, Shao-An, et al.
Publicado: (2007)

Parthenolide induces apoptosis and lytic cytotoxicity in Epstein-Barr virus-positive Burkitt lymphoma
por: LI, YUAN, et al.
Publicado: (2012)

Therapies based on targeting Epstein‐Barr virus lytic replication for EBV‐associated malignancies
por: Li, Hongde, et al.
Publicado: (2018)

A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells
por: Ersing, Ina, et al.
Publicado: (2017)

Pseudouridylation of Epstein-Barr virus noncoding RNA EBER2 facilitates lytic replication
por: Henry, Belle A., et al.
Publicado: (2022)

The Dual Functions of Andrographolide in the Epstein–Barr Virus-Positive Head-and-Neck Cancer Cells: The Inhibition of Lytic Reactivation of the Epstein–Barr Virus and the Induction of Cell Death
por: Heawchaiyaphum, Chukkris, et al.
Publicado: (2023)

Autophagy-Dependent Reactivation of Epstein-Barr Virus Lytic Cycle and Combinatorial Effects of Autophagy-Dependent and Independent Lytic Inducers in Nasopharyngeal Carcinoma
por: Yiu, Stephanie Pei Tung, et al.
Publicado: (2019)

Inhibition of Poly(ADP-ribose)polymerase impairs Epstein Barr Virus lytic cycle progression
por: Mattiussi, Stefania, et al.
Publicado: (2007)

MCAF1 and synergistic activation of the transcription of Epstein–Barr virus lytic genes by Rta and Zta
por: Chang, Li-Kwan, et al.
Publicado: (2010)

The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis
por: Morales-Sánchez, Abigail, et al.
Publicado: (2018)

Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps
por: Keck, Kristin M., et al.
Publicado: (2017)

PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter
por: Lupey-Green, Lena N., et al.
Publicado: (2017)

Lytic Induction Therapy against Epstein–Barr Virus-Associated Malignancies: Past, Present, and Future
por: Yiu, Stephanie Pei Tung, et al.
Publicado: (2020)

Subclinical Epstein-Barr Virus Primary Infection and Lytic Reactivation Induce Thyrotropin Receptor Autoantibodies
por: Tamoto, Naohiro, et al.
Publicado: (2019)

Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein–Barr Virus
por: Deng, Yun, et al.
Publicado: (2021)

Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric Cancer
por: Malat, Praphatson, et al.
Publicado: (2021)

Contribution of Epstein–Barr Virus Lytic Proteins to Cancer Hallmarks and Implications from Other Oncoviruses
por: Dorothea, Mike, et al.
Publicado: (2023)

B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection
por: Romero-Masters, James C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s2sbo8ek4sq5q48hodjf638mqt